Despite the limited number of RCTs that have evaluated GLP-1 agonists in OSA to date,26,80, 81, 82 several meta-analyses25,36,61,83,84 have synthesised findings from these studies, suggesting that GLP-1 receptor agonists may offer therapeutic benefits for patients with OSA. Here, GLP1R is linked to obstructive sleep apnea syndrome.